Global mRNA Vaccines & Therapeutics Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-48995 | Geographical Scope: Global | Publisher: HNY Research
The global mRNA Vaccines & Therapeutics market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Moderna Therapeutics eTheRNA BioNTech CureVac In-Cell-Art Translate Bio Tiba Biotechnology Argos Therapeutics Sangamo Therapeutics Ethris By Types: Standardization Of Cancer Treatment MRNA Vaccine Individualized Cancer Treatment MRNA Vaccine Infectious Disease Treatment MRNA Vaccine Infection Prevention MRNA Vaccine By Applications: Infectious Disease Cancer Other Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by mRNA Vaccines & Therapeutics Revenue 1.5 Market Analysis by Type 1.5.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Standardization Of Cancer Treatment MRNA Vaccine 1.5.3 Individualized Cancer Treatment MRNA Vaccine 1.5.4 Infectious Disease Treatment MRNA Vaccine 1.5.5 Infection Prevention MRNA Vaccine 1.6 Market by Application 1.6.1 Global mRNA Vaccines & Therapeutics Market Share by Application: 2022-2027 1.6.2 Infectious Disease 1.6.3 Cancer 1.6.4 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global mRNA Vaccines & Therapeutics Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global mRNA Vaccines & Therapeutics Market Players Profiles 3.1 Moderna Therapeutics 3.1.1 Moderna Therapeutics Company Profile 3.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Specification 3.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 eTheRNA 3.2.1 eTheRNA Company Profile 3.2.2 eTheRNA mRNA Vaccines & Therapeutics Product Specification 3.2.3 eTheRNA mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 BioNTech 3.3.1 BioNTech Company Profile 3.3.2 BioNTech mRNA Vaccines & Therapeutics Product Specification 3.3.3 BioNTech mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 CureVac 3.4.1 CureVac Company Profile 3.4.2 CureVac mRNA Vaccines & Therapeutics Product Specification 3.4.3 CureVac mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 In-Cell-Art 3.5.1 In-Cell-Art Company Profile 3.5.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Specification 3.5.3 In-Cell-Art mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Translate Bio 3.6.1 Translate Bio Company Profile 3.6.2 Translate Bio mRNA Vaccines & Therapeutics Product Specification 3.6.3 Translate Bio mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Tiba Biotechnology 3.7.1 Tiba Biotechnology Company Profile 3.7.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Specification 3.7.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Argos Therapeutics 3.8.1 Argos Therapeutics Company Profile 3.8.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Specification 3.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Sangamo Therapeutics 3.9.1 Sangamo Therapeutics Company Profile 3.9.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Specification 3.9.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Ethris 3.10.1 Ethris Company Profile 3.10.2 Ethris mRNA Vaccines & Therapeutics Product Specification 3.10.3 Ethris mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global mRNA Vaccines & Therapeutics Market Competition by Market Players 4.1 Global mRNA Vaccines & Therapeutics Production Capacity Market Share by Market Players (2016-2021) 4.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Market Players (2016-2021) 4.3 Global mRNA Vaccines & Therapeutics Average Price by Market Players (2016-2021) 5 Global mRNA Vaccines & Therapeutics Production by Regions (2016-2021) 5.1 North America 5.1.1 North America mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.1.2 mRNA Vaccines & Therapeutics Key Players in North America (2016-2021) 5.1.3 North America mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.1.4 North America mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.2.2 mRNA Vaccines & Therapeutics Key Players in East Asia (2016-2021) 5.2.3 East Asia mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.2.4 East Asia mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.3.2 mRNA Vaccines & Therapeutics Key Players in Europe (2016-2021) 5.3.3 Europe mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.3.4 Europe mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.4.2 mRNA Vaccines & Therapeutics Key Players in South Asia (2016-2021) 5.4.3 South Asia mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.4.4 South Asia mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.5.2 mRNA Vaccines & Therapeutics Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.5.4 Southeast Asia mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.6.2 mRNA Vaccines & Therapeutics Key Players in Middle East (2016-2021) 5.6.3 Middle East mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.6.4 Middle East mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.7.2 mRNA Vaccines & Therapeutics Key Players in Africa (2016-2021) 5.7.3 Africa mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.7.4 Africa mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.8.2 mRNA Vaccines & Therapeutics Key Players in Oceania (2016-2021) 5.8.3 Oceania mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.8.4 Oceania mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.9.2 mRNA Vaccines & Therapeutics Key Players in South America (2016-2021) 5.9.3 South America mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.9.4 South America mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World mRNA Vaccines & Therapeutics Market Size (2016-2021) 5.10.2 mRNA Vaccines & Therapeutics Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) 5.10.4 Rest of the World mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) 6 Global mRNA Vaccines & Therapeutics Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America mRNA Vaccines & Therapeutics Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia mRNA Vaccines & Therapeutics Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia mRNA Vaccines & Therapeutics Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia mRNA Vaccines & Therapeutics Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East mRNA Vaccines & Therapeutics Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa mRNA Vaccines & Therapeutics Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania mRNA Vaccines & Therapeutics Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America mRNA Vaccines & Therapeutics Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World mRNA Vaccines & Therapeutics Consumption by Countries 7 Global mRNA Vaccines & Therapeutics Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of mRNA Vaccines & Therapeutics (2022-2027) 7.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics (2022-2027) 7.3 Global Forecasted Price of mRNA Vaccines & Therapeutics (2022-2027) 7.4 Global Forecasted Production of mRNA Vaccines & Therapeutics by Region (2022-2027) 7.4.1 North America mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.2 East Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.3 Europe mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.4 South Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.6 Middle East mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.7 Africa mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.8 Oceania mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.9 South America mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World mRNA Vaccines & Therapeutics Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of mRNA Vaccines & Therapeutics by Application (2022-2027) 8 Global mRNA Vaccines & Therapeutics Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.2 East Asia Market Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.3 Europe Market Forecasted Consumption of mRNA Vaccines & Therapeutics by Countriy 8.4 South Asia Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.5 Southeast Asia Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.6 Middle East Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.7 Africa Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.8 Oceania Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.9 South America Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 8.10 Rest of the world Forecasted Consumption of mRNA Vaccines & Therapeutics by Country 9 Global mRNA Vaccines & Therapeutics Sales by Type (2016-2027) 9.1 Global mRNA Vaccines & Therapeutics Historic Market Size by Type (2016-2021) 9.2 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Type (2022-2027) 10 Global mRNA Vaccines & Therapeutics Consumption by Application (2016-2027) 10.1 Global mRNA Vaccines & Therapeutics Historic Market Size by Application (2016-2021) 10.2 Global mRNA Vaccines & Therapeutics Forecasted Market Size by Application (2022-2027) 11 Global mRNA Vaccines & Therapeutics Manufacturing Cost Analysis 11.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics 12 Global mRNA Vaccines & Therapeutics Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 mRNA Vaccines & Therapeutics Distributors List 12.3 mRNA Vaccines & Therapeutics Customers 12.4 mRNA Vaccines & Therapeutics Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Non-Hodgkin Lymphoma Therapeutics Market
$2000-$6000
Acrylic Teeth Market
$3600-$7000